FMCKL Stock | News | Quote | Stock Forum | Thursday, October

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Freddie Mac FMCKL Company Overview 

Stock Message Board http://investorshangout.com/search?q=FMCKL&am...mp;yt1=Go!

Last Updated: Thursday, October 24, 2013 7:42:07 PM

Freddie Mac FMCKL Current Price and Quotes
Last Price 5.50
Previous Close 5.49 Open 5.44
Daily Range 6.00 - 5.40 52wk Range 6.00 - 1.15
Volume 1,162,400 Dividend N/A
Average Vol (3m) 7,734 Yield N/A
Freddie Mac FMCKL
Company Information

8200 Jones Branch Drive
McLean, VA 22102

Website: http://www.freddiemac.com
Phone: 703-903-2000

Freddie Mac FMCKL
Freddie Mac was chartered by Congress in 1970 with a public mission to stabilize the nation’s residential mortgage markets and expand opportunities for home ownership and affordable rental housing.

Freddie Mac FMCKL
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Not Available
Latest Report Jun 30, 2013 10-Q
CIK 0001026214
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 6111 - Federal and federally sponsored credit
Incorporated In: USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts

Donald H. Layton CEO
Ross J. Kari CFO
John R. Dye Senior VP, Corporate Secretary
Company Directors

Not Available
Company Notes

Formerly=Federal Home Loan Mortgage Corp. until 7-97
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

Freddie Mac FMCKL
FMCKL Security Details Other Company Securities

Share Structure

Market Value1 $109,800,000 a/o Oct 23, 2013
Shares Outstanding 20,000,000 a/o Jul 24, 2007
Float Not Available
Authorized Shares Not Available
Par Value  No Par Value
Shareholders

Shareholders of Record Not Available
Short Selling Data

Short Interest 0 (-100%)
Sep 30, 2013
Significant Failures to Deliver  No
Transfer Agent(s)



Freddie Mac FMCKL Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue 80,635,000 88,262,000 98,368,000 37,614,000
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses

Research and Development - - - -
Sales, General and Admin. 2,193,000 2,483,000 2,932,000 7,195,000
Non-Recurring Items - - - -
Other 1,890,000 10,702,000 17,218,000 29,530,000
Operating Income - - - -
Income From Continuing Operations

Add'l Income/Expense Items - - - -
Earnings Before Interest and Tax 76,552,000 75,077,000 78,218,000 889,000
Interest Expense 67,107,000 80,743,000 93,100,000 23,273,000
Earnings Before Tax 9,445,000 (5,666,000) (14,882,000) (22,384,000)
Income Tax (1,537,000) (400,000) (856,000) (830,000)
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 10,982,000 (5,266,000) (14,026,000) (21,554,000)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 10,982,000 (5,266,000) (14,026,000) (21,554,000)
Preferred Stock and Other Adjustments (13,056,000) (6,498,000) (5,749,000) (4,105,000)
Net Income Applicable to Common Shareholders (2,074,000) (11,764,000) (19,774,000) (25,658,000)

Freddie Mac FMCKL Recent News

FMCKL Freddie Mac Research DD Guide

Stock Message Board http://investorshangout.com/search?q=FMCKL&am...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/FMCKL/quote
Stock Chart http://www.otcmarkets.com/stock/FMCKL/chart
Company Info http://www.otcmarkets.com/stock/FMCKL/company-info
Recent News http://www.otcmarkets.com/stock/FMCKL/news
Financials http://www.otcmarkets.com/stock/FMCKL/financials
Filings and Disclosure http://www.otcmarkets.com/stock/FMCKL/filings
Short Sales http://www.otcmarkets.com/stock/FMCKL/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/FMCKL/insider-transactions
Research Reports http://www.otcmarkets.com/stock/FMCKL/research
Summary http://finance.yahoo.com/q?s=FMCKL
Historical Prices http://finance.yahoo.com/q/hp?s=FMCKL+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=FMCKL
Basic Chart http://finance.yahoo.com/q/bc?s=FMCKL+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=FMCKL+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=FMCKL+Headlines
Press Releases http://finance.yahoo.com/q/p?s=FMCKL+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=FMCKL+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=FMCKL+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=FMCKL+Industry
Major Holders http://finance.yahoo.com/q/mh?s=FMCKL+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=FMCKL+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=FMCKL+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=FMCKL
Balance Sheet http://finance.yahoo.com/q/bs?s=FMCKL
Cash Flow http://finance.yahoo.com/q/cf?s=FMCKL+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/FMCKL
Market Watch http://www.marketwatch.com/investing/stock/FMCKL
Bloomberg http://www.bloomberg.com/quote/FMCKL:US
Morningstar http://quotes.morningstar.com/stock/s?t=FMCKL
Bussinessweek http://investing.businessweek.com/research/st...cker=FMCKL
Barchart http://www.barchart.com/quotes/stocks/FMCKL
OTC Short Report http://otcshortreport.com/index.php?index=FMCKL
Investopedia http://www.investopedia.com/markets/stocks/FMCKL/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 311

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 138

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 627

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Xiaomi's Smart Auto Factory Draws Global Media Praise

Updated Category News Views 58

Xiaomi Impresses Global Media in Beijing Factory Tour In the ever-changing world of NEVs (New Energy Vehicles), a tour of Xiaomi's smart auto factory in Beijing has made waves among global media folks. These scribes got an up-close look at Xiaomi's magic mix of tech and style on November 6, part of a grand media gathering. What's Under the Hood? Marcos Costa de Oliveira,...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 357

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 108

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 358

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 250

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 351

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 559

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading

Top 5 Most Recently Viewed Articles

Assessing TJX Companies Inc: Market Sentiment and Performance

Updated Category News Views 199

Understanding TJX Companies Inc's Market Dynamics TJX Companies Inc (NYSE: TJX) is currently navigating an intriguing landscape in the stock market, characterized by an increase in short interest. Notably, the short interest as a percentage of float has surged by 6.82% since the latest report, with approximately 15.68 million shares now sold short. This accounts for 1.41%...

Continue Reading
Refresco Teamsters Achieve Historic Contractual Victory

Updated Category News Views 337

Historic Contract Ratified by Teamsters Local 767 Members of Teamsters Local 767 have made headlines with their recent contract ratification that promises significant improvements for the workers of Refresco. An overwhelming majority of 93 percent voted in favor of this new agreement, showcasing the unity and commitment of the union members. Support for Employees The...

Continue Reading
MAP Medical and Metrix-Secure Team Up for Enhanced Healthcare

Updated Category News Views 133

MAP Medical Partners with Metrix-Secure for Enhanced Services MAP Medical has officially partnered with Metrix-Secure, a recognized leader in the medical supply industry. This collaboration empowers MAP Medical to serve as an authorized distributor, providing quality medical supply solutions to a wide array of healthcare facilities. Enhancing Patient Care with Reliable...

Continue Reading
Investors Show Interest in Unusual Options for Marriott

Updated Category News Views 153

Insights into Unusual Options Activity for Marriott International Recently, there has been a notable surge in bearish sentiment among investors concerning Marriott International (NASDAQ: MAR). This shift in attitude is essential for retail traders to understand as it may indicate changes in the market landscape. These trading patterns were identified through a publicly...

Continue Reading
Caribou Biosciences Investors Have Legal Avenues Available

Updated Category News Views 135

Opportunity for Investors of Caribou Biosciences For those who invested in Caribou Biosciences, Inc. (NASDAQ: CRBU), an exciting opportunity has emerged concerning potential legal claims. The Rosen Law Firm, recognized for its dedication to investor rights, is actively reminding purchasers of Caribou securities of their rights. If you bought securities between July 14,...

Continue Reading